Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 23, 2022 02:00 ET | Source: iosBio

iosBio receives UK grant to develop oral vaccine against Nipah virus

PRESS RELEASE iosBio receives UK grant to develop oral vaccine against Nipah virus Zoonotic virus often cited as future pandemic threat and requiring urgent R&D actioniosBio’s oral vaccine...
June 14, 2021 02:00 ET | Source: iosBio

iosBio appoints Patricia Londono-Hayes as Chief Development Officer

PRESS RELEASE iosBio appoints Patricia Londono-Hayes as Chief Development Officer Oral vaccines and biotherapeutics company strengthens senior leadership team with new role to drive priority...
January 12, 2021 07:00 ET | Source: iosBio

iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19

PRESS RELEASE iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19 iosBio licenses its OraProTM...
January 12, 2021 02:00 ET | Source: iosBio

iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19

PRESS RELEASE iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19 iosBio licenses its OraProTM...
September 30, 2020 02:00 ET | Source: iosBio

Stabilitech Biopharma announces name change to iosBio

PRESS RELEASE Stabilitech Biopharma announces name change to iosBio Burgess Hill, UK, 30 September 2020, STABILITECH BIOPHARMA (the “Company”), a UK-based biotechnology company developing next...